Zdrowie i gospodarka · 15/12/2021
FDA Classifies Nonimplanted Nerve Stimulator for Functional Abdominal Pain Relief into Class II with Special Controls
The FDA has classified the nonimplanted nerve stimulator for functional abdominal pain relief into Class II with special controls, aiming to ensure the device's safety and effectiveness while enhancing patients' access to innovative treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →